Zobrazeno 1 - 8
of 8
pro vyhledávání: '"J, Billich"'
Autor:
James Lee, A. Naegeli, Narayanan Ramasamy, T. J. Billich, David H. Laforge, P. J. Miller, Peer M. Portner, Jal S. Jassawalla
Publikováno v:
ASAIO journal (American Society for Artificial Internal Organs : 1992). 40(3)
The Novacor left ventricular assist system (LVAS), an implanted electromechanically driven blood pump, has been used in an ongoing clinical trial as a bridge to cardiac transplantation since 1984. The initial configuration included a console based ex
Autor:
M A, Daniel, J, Lee, D H, LaForge, H, Chen, J, Billich, P J, Miller, N, Ramasamy, L R, Strauss, J S, Jassawalla, P M, Portner
Publikováno v:
ASAIO transactions. 37(3)
The totally implantable Novacor left ventricular assist system (LVAS) is currently approaching clinical evaluation. In vivo testing and production are underway with National Institutes of Health (NIH) support. Activity over the past year has focused
Autor:
Phillip J. Miller, Narayanan Ramasamy, James Lee, E. Conner, Herb Chen, Jal S. Jassawalla, Peer M. Portner, J. Billich, Novacor, D J LaForge
Publikováno v:
ASAIO Journal. 42:55
Autor:
T. J. Billich, M. Ryan, B. Sohrab, James Lee, Peer M. Portner, David H. Laforge, Jal S. Jassawalla
Publikováno v:
Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
An implantable electronic control and power (IECP) system for a totally implantable left ventricular assist system has been developed for long-term human use. The control and power system consists of a single-chip microprocessor that is interfaced to
Publikováno v:
Basic Aspects of Blood Trauma ISBN: 9789024722792
Extracorporeal circulatory systems for oxygenation of blood are an important tool of modern heart surgery (1, 10, 17, 18). In addition, those devices became recently applicable for therapeutic assist in patients with pulmonary insufficiency (9, 25).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8b6d5533d9999f3bd6a5374f1dd0a52
https://doi.org/10.1007/978-94-009-9337-2_13
https://doi.org/10.1007/978-94-009-9337-2_13
Autor:
J S, Jassawalla, M A, Daniel, H, Chen, J, Lee, D, LaForge, J, Billich, N, Ramasamy, P J, Miller, P E, Oyer, P M, Portner
Publikováno v:
ASAIO transactions. 34(3)
The totally implantable Novacor LVAS is being tested under NIH auspices to demonstrate safety and efficacy before clinical trials. Twelve complete systems (submerged in saline at 37 degrees C) are being tested, with an NIH goal of demonstrating 80% r
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Daniel MA; Novacor Division, Baxter Healthcare Corporation, Oakland, California 94621., Lee J, LaForge DH, Chen H, Billich J, Miller PJ, Ramasamy N, Strauss LR, Jassawalla JS, Portner PM
Publikováno v:
ASAIO transactions [ASAIO Trans] 1991 Jul-Sep; Vol. 37 (3), pp. M423-5.